05:15 PM EST, 11/06/2025 (MT Newswires) -- Globus Medical ( GMED ) reported Q3 non-GAAP earnings late Thursday of $1.18 per diluted share, up from $0.83 a year earlier.

Analysts polled by FactSet expected $0.78.

Net sales for the quarter ended Sept. 30 were $769.0 million, up from $625.7 million a year earlier.

Analysts surveyed by FactSet expected $734.7 million.

The company adjusted its full-year adjusted EPS guidance to be in the range of $3.75 to $3.85 and revenue of $2.86 billion to $2.90 billion from an EPS of $3.00 to $3.30 and revenue of $2.80 billion to $2.90 billion previously.

Analysts expected EPS of $3.21 on revenue of $2.86 billion.

Shares of the company were up 19% in after-hours trading.